Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Telix Pharmaceuticals Ltd/ 6-K

SEC Filing · 6-K

Telix Pharmaceuticals Ltd

TLPPFOTCEQUITYCurrent

SEC Filing

Filed Sep 14, 2026Accepted Sep 14, 2026, 4:52 PM EDTCIK 2007191Accession 0001628280-26-061892
View company →Permanent SEC source ↗
Share

Company context

Current securities

TLPPFOTC · EQUITY · CurrentTLXNASDAQ · ADR · Current

Recent company filings

  1. 6-K filingSep 21, 2026
  2. 6-K filingSep 2, 2026
  3. 6-K filingSep 1, 2026
  4. 6-K filingAug 20, 2026
  5. 6-K filingJul 21, 2026

As-filed source

Primary evidence
As filedOpen full document ↗